Affinity Asset Advisors’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$1.54M Sell
2024
Q1
$4.48M Hold
2023
Q4
$2.32M Sell
2023
Q3
$3.62M Buy
2021
Q3
Sell
2021
Q2
$1.15M Hold
2021
Q1
$1.38M Buy
2020
Q4
$1.33M Buy